EcoDrugPlus

Arachidonate 12-Lipoxygenase, 12s-Type-Like

Ensembl ID : ENSMLUG00000022526
Gene Symbol: LOC102428351
3 Cross references
193 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s-Type-Like

Ensembl ID : ENSMLUG00000026739
Gene Symbol: LOC102429158
3 Cross references
193 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSMLUG00000003847
Gene Symbol: ALOX5
2 Cross references
220 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSMLUG00000006023
Gene Symbol: ALOX5AP
2 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSMLUG00000011398
Gene Symbol: AVPR1A
2 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSMLUG00000010328
Gene Symbol: AVPR1B
4 Cross references
134 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSMLUG00000014253
Gene Symbol: AVPR2
2 Cross references
231 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSMLUG00000000097
Gene Symbol: AHR
2 Cross references
154 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSMLUG00000007925
Gene Symbol: AURKA
2 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSMLUG00000003633
Gene Symbol: AURKB
2 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSMLUG00000007587
Gene Symbol: AURKC
2 Cross references
96 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSMLUG00000007898
Gene Symbol: BACE1
2 Cross references
217 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).